Lariam and Delusion - a phase IV clinical study of FDA data

Summary:

Delusion is reported as a side effect among people who take Lariam (mefloquine hydrochloride), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Valium, and have Depression.

The phase IV clinical study analyzes which people have Delusion when taking Lariam. It is created by eHealthMe based on reports of 3,078 people who have side effects when taking Lariam from the FDA, and is updated regularly.

What is Lariam?

Lariam has active ingredients of mefloquine hydrochloride. It is often used in malaria. eHealthMe is studying from 3,145 Lariam users. Check the latest studies of Lariam.

What is Delusion?

Delusion (a false belief or opinion) is found to be associated with 906 drugs and 1,092 conditions by eHealthMe. Check the latest studies of Delusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

3,078 people reported to have side effects when taking Lariam.
Among them, 73 people (2.37%) have Delusion.

Among these 73 people:

How long have people been on Lariam when they have Delusion? *

What is the gender of people who have Delusion when taking Lariam? *

female: 47.83 %
male: 52.17 %

What is the age of people who have Delusion when taking Lariam? *

What are other drugs people take besides Lariam? *

What are other side effects people have besides Delusion? *

Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 28 people, 38.36%
Agitation (state of anxiety or nervous excitement): 19 people, 26.03%
Aggression: 16 people, 21.92%
Fatigue (feeling of tiredness): 15 people, 20.55%
Memory Loss: 13 people, 17.81%
Psychotic Disorder: 13 people, 17.81%
Depression: 13 people, 17.81%
Confusional State: 13 people, 17.81%
Confusion: 13 people, 17.81%
Headache (pain in head): 12 people, 16.44%

What are the existing conditions these people have? *

Depression: 7 people, 9.59%

* Approximation only. Some reports may have incomplete information.

Do you take Lariam and have Delusion?

- Check whether Delusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lariam:

Lariam (3,145 reports)

Delusion treatments and more:

Delusion (36,893 reports)

Browse all side effects of Lariam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Delusion:

Delusion (906 drugs)

Browse all the conditions that are associated with Delusion:

Delusion (1,092 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mefloquine hydrochloride (the active ingredients of Lariam) and Lariam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.